Blood bacterial DNA signatures in a prospective cohort of patients with liver cirrhosis
This study aimed to determine whether detection of bacterial DNA in blood could be associated with development of hepatocellular carcinoma (HCC) in metabolic dysfunction-associated steatotic liver disease (MASLD) patients with liver cirrhosis.